Show
Sort by
-
- Journal Article
- A1
- open access
Shaping the future of respiratory care : a look into the next decade and strategic recommendations by the European Forum for Research and Education in Allergy and Airways Diseases
-
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST) : a multicentre, randomised, double-blind, head-to-head phase 4 trial
-
- Journal Article
- A1
- open access
Response to biologics along a gradient of T2 involvement in patients with severe asthma : a data-driven biomarker clustering approach
-
Prevention of cardiovascular and other systemic adverse outcomes in patients with asthma treated with biologics
-
- Journal Article
- A1
- open access
Impact of biologics initiation on oral corticosteroid use in the International Severe Asthma Registry and the Optimum Patient Care Research Database : a pooled analysis of real-world data
-
- Journal Article
- A1
- open access
The epithelial era of asthma research : knowledge gaps and future direction for patient care
-
- Journal Article
- A1
- open access
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
-
- Miscellaneous
- open access
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
AROMA : real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps
-
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies